With the fast evolving regulatory environment in Asia, stricter guidelines on Risk Management Plan (RMP) is expected to kick in that will have far-reaching consequences. These plans are all in accordance to the goal of improving drug safety in the Asian region but addressing the problem head on will not be easy, given the hard challenges that the PV sector faces. This article considers these challenges as well as way to improve PV standards.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |